Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 460 participants.
Also called NCT00737152
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 460 participants
- Sponsor
- American Scitech International
- Registry
-
NCT00737152
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, India
- Registry status
- Unknown status
Technical summary
Registry record NCT00737152. Non-randomized; no masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2014-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
- Acronym
- ASI-DMII
- Condition
- Type II Diabetes Mellitus
- Intervention (Other)
- RAS 130 with diet and exercise
- Lead sponsor
- American Scitech International
- Collaborator
- Proactive Clinical Research
Record details
- Record id
cardio:ct-nct00737152- Content hash
2e3f0594153c0a94ed73a61fd6a63f3e3a0689ebf1266c13678b30dad5424d3a